Statements (20)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:person
|
| gptkbp:boardMemberOf |
gptkb:BIO_(Biotechnology_Innovation_Organization)
gptkb:Pharmaceutical_Research_and_Manufacturers_of_America_(PhRMA) |
| gptkbp:dateOfBirth |
1948
|
| gptkbp:education |
gptkb:Cornell_University
gptkb:University_of_Massachusetts_Amherst |
| gptkbp:employer |
gptkb:Biogen
gptkb:Exelixis gptkb:Vir_Biotechnology |
| gptkbp:fieldOfWork |
gptkb:biotechnology
pharmaceutical industry |
| https://www.w3.org/2000/01/rdf-schema#label |
George Scangos
|
| gptkbp:nationality |
gptkb:American
|
| gptkbp:notableWork |
leadership in COVID-19 response
|
| gptkbp:occupation |
biologist
|
| gptkbp:positionHeld |
CEO of Biogen
CEO of Exelixis CEO of Vir Biotechnology |
| gptkbp:bfsParent |
gptkb:Vir_Biotechnology
|
| gptkbp:bfsLayer |
6
|